-
NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs
2020-12-28
The NMPA has enabled and officially launched on January 1, 2021 the online application module for drug registration affairs.
-
SAMR Released the Provisions for the Lot Release of Biological Products
2020-12-21
NMPA drafted the Provisions for the Lot Release of Biological Products (hereinafter referred to as the Provisions ).
-
Center for Drug Evaluation of NMPA Announced on Issuing the Administrative Measures for Communication of Drug R&D and Technical Review
2020-12-11
The Center for Drug Evaluation organized the revision of the Administrative Measures for Communication of Drug R&D and Technical Review, been released with NMPA's examination and approval for implementation as from December 10, 2020.
-
NMPA issued the Announcement on Matters Concerning the Production of Imported Medical Devices in Domestic Enterprises in China
2020-09-25
On September 18, 2020, NMPA announced the following matters concerning the production of products with imported medical device registration certificates in domestic enterprises in China.
-
NMPA and General Administration of Customs issued the Announcement on the Setting up of Wuxi Airport and Jiangyin Port as Drug Import Ports
2020-09-14
On September 2, 2020, NMPA and General Administration of Customs issued the following announcement.
-
NMPA issued the Announcement on Provisions for the Filing of Medical Representatives (Interim)
2020-09-30
NMPA has organized to formulate the Provisions for the Filing of Medical Representatives (Interim), which was issued on September 22, 2020.